Passage Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2024 | 3 | -$0.28 | -$0.17 | -$0.23 |
| Q3 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q1 2025 | 2 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2025 | 2 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2025 | 2 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 2 | -$0.16 | -$0.16 | -$0.16 |
Passage Bio, Inc. Earnings Date And Information
Passage Bio, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.31 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Passage Bio, Inc. has generated $-2 earnings per share over the last year ($-1.86 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Passage Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Passage Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.31 | -$0.26 | 0.05 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.37 | -$0.30 | 0.07 | $0 | |
| 03/04/2024 | Q4 2023 | -$0.41 | -$0.31 | 0.1 | $5.91 M | |
| 11/13/2023 | Q3 2023 | -$0.47 | -$0.49 | -0.02 | $0 | |
| 08/07/2023 | Q2 2023 | -$0.48 | -$0.44 | 0.04 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.49 | -$0.60 | -0.11 | $0 | |
| 03/06/2023 | Q4 2022 | -$0.48 | -$0.47 | 0.01 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.75 | -$0.48 | 0.27 | $0 | |
| 08/04/2022 | Q2 2022 | -$0.78 | -$0.72 | 0.06 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.88 | -$0.79 | 0.09 | $0 | |
| 03/03/2022 | Q4 2021 | -$0.84 | -$0.95 | -0.11 | $0 | |
| 11/04/2021 | Q3 2021 | -$0.80 | -$0.87 | -0.07 | $0 | |
| 08/05/2021 | Q2 2021 | -$0.73 | -$0.90 | -0.17 | $0 | |
| 05/05/2021 | Q1 2021 | -$0.66 | -$0.76 | -0.1 | $0 | |
| 03/03/2021 | Q4 2020 | -$0.69 | -$0.85 | -0.16 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.73 | -$0.63 | 0.1 | $0 | |
| 08/13/2020 | Q2 2020 | -$0.60 | -$0.60 | 0 | $0 | |
| 05/11/2020 | Q1 2020 | -$0.46 | -$1.00 | -0.54 | $0 | |
| 12/30/2019 | Q4 2019 | -$0.55 | $0 | |||
| 09/29/2019 | Q3 2019 | -$0.48 | $0 |
Passage Bio, Inc. Earnings: Frequently Asked Questions
-
When is Passage Bio, Inc.'s earnings date?
Passage Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Passage Bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, Passage Bio, Inc. (:PASG) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.31 by $0.05.
-
How can I listen to Passage Bio, Inc.'s earnings conference call?
The conference call for Passage Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Passage Bio, Inc.'s conference call transcript?
The conference call transcript for Passage Bio, Inc.'s latest earnings report can be read online.
-
How much profit does Passage Bio, Inc. generate each year?
Passage Bio, Inc. (:PASG) has a recorded net income of $0. Passage Bio, Inc. has generated $-1.86 earnings per share over the last four quarters.
-
What is Passage Bio, Inc.'s price-to-earnings ratio?
Passage Bio, Inc. (:PASG) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is -0.04.
